RecruitingNCT07088874

Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy

Novel Biomarkers to Predict Acute Kidney Injury and Chronic Kidney Disease After Radical Nephrectomy: an Exploratory Prospective Cohort Study


Sponsor

Peking University First Hospital

Enrollment

60 participants

Start Date

Aug 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The incidence of acute kidney injury (AKI) after radical nephrectomy exceeds 40%. Currently, the KDIGO criteria are the recognized diagnostic standard for AKI. These criteria primarily use serum creatinine and urine output as key indicators, but both parameters have certain limitations, such as delayed response, insensitivity, and inaccuracy. This study aims to simultaneously monitor perioperative novel renal damaging, stressful, and functional biomarkers in patients undergoing radical nephrectomy, and to investigate their predictive value for AKI and postoperative 1-year chronic kidney disease (CKD).


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age ≥18 years;
  • Scheduled to undergo unilateral radical nephrectomy.

Exclusion Criteria4

  • Solitary kidney;
  • Preoperative diagnosis of chronic kidney disease stages G4 or G5 (GFR \<30 mL/min/1.73m²);
  • Tumor invasion of the vena cava requiring thrombectomy;
  • Other conditions deemed by the investigator as unsuitable for participation in this study.

Locations(1)

Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07088874


Related Trials